CD300ld promotes neutrophil bacterial phagocytosis in sepsis
Journal of Leukocyte Biology · 2025
DOI: 10.1093/jleuko/qiaf063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Yuichi Akama und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, 350 Community Drive, Manhasset, NY 11030, United States. Hauptthemen laut MEDLINE: Phagocytosis, Neutrophils, Sepsis, Receptors, Immunologic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NIH HHS.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a life-threatening condition caused by a dysregulated immune response to infection. Neutrophils act as first line of defense against infection, but their function can become impaired in sepsis. CD300 antigen-like family member d (CD300ld), predominantly expressed on neutrophils, associates with Fc receptor common gamma-chain (FcRγ chain), a component vital for phagocytosis. In this study, we investigated the role of CD300ld in neutrophil phagocytosis. Our results demonstrate a marked decrease in CD300ld expression on neutrophils isolated from both septic mice and patients. CD300ld was positively correlated with bacterial phagocytosis in neutrophils. The transcriptomic analysis of CD300ld knock-out neutrophils revealed a downregulation of genes related to defense response to bacteria, suggesting that CD300ld is a key modulator of bacterial clearance. Stimulation of CD300ld with an agonist antibody in neutrophils led to the activation of Rac2, a key regulator of actin polymerization, facilitating the enhanced phagocytosis. Furthermore, CD300ld activation significantly enhanced the in vitro phagocytosis of Escherichia coli and Staphylococcus aureus by neutrophils. Septic mice adoptively transferred with CD300ld-activated neutrophils exhibited markedly reduced bacterial loads in the blood and peritoneum, decreased inflammatory cytokine levels, and alleviated organ injury. These findings highlight the critical role of CD300ld signaling in neutrophil-mediated bacterial clearance in sepsis and provide a solid foundation for future research aimed at developing novel immunotherapies against this deadly disease condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, 350 Community Drive, Manhasset, NY 11030, United States.
- Departments of Surgery and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, 500 Hofstra Blvd, Hempstead, NY 11549, United States.
ORCID-Profile: Ping Wang
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Akama, Y., Murao, A., Aziz, M., & Wang, P. (2025). CD300ld promotes neutrophil bacterial phagocytosis in sepsis. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiaf063
Vancouver
Akama Y, Murao A, Aziz M, Wang P. CD300ld promotes neutrophil bacterial phagocytosis in sepsis. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiaf063
BibTeX
@article{Akama2025,
author = {Akama, Yuichi and Murao, Atsushi and Aziz, Monowar and Wang, Ping},
title = {CD300ld promotes neutrophil bacterial phagocytosis in sepsis},
journal = {Journal of Leukocyte Biology},
year = {2025},
doi = {10.1093/jleuko/qiaf063}
}
EUVIMED